Alexion Pharma (NASDAQ: ALXN) announced that its Board of Directors has appointed David L. Hallal as the Company’s Chief Executive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE